168 results
8-K
EX-99.1
ELOX
Eloxx Pharmaceuticals, Inc.
13 Nov 23
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
4:58pm
, offset by a decrease of $0.1 million related to facility and overhead expenses.
As of September 30, 2023, we had unrestricted cash and cash equivalents
8-K
EX-99.1
e1pvd 01usy
17 Aug 21
Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
12:00am
DEFA14A
7wdlwjw lais5
1 Apr 21
Additional proxy soliciting materials
4:16pm